Inventor
SCHNUTE MARK EDWARD
US12 patents
Patents
12 patentsUS10426135B2Oct 1, 2019
Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
PFIZER2 citations71
US10227346B2Mar 12, 2019
Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therof
PFIZER1 citations71
US9920054B2Mar 20, 2018
Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
PFIZER2 citations71
US9670201B2Jun 6, 2017
Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
PFIZER3 citations71
US10266513B2Apr 23, 2019
Bruton's tyrosine kinase inhibitors
PFIZER2 citations70
US11708360B2Jul 25, 2023
N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors
PFIZER2 citations68
US10975065B2Apr 13, 2021
N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors
PFIZER3 citations68
US10385036B2Aug 20, 2019
Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof
PFIZER1 citations61
US10336748B2Jul 2, 2019
Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
PFIZER1 citations61
US11655252B2May 23, 2023
Aminopyrimidinyl derivatives
PFIZER0 citations59
US12312344B2May 27, 2025
N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors
PFIZER0 citations58
US10815213B2Oct 27, 2020
Bruton's tyrosine kinase inhibitors
PFIZER0 citations49